CHC – The Cancer & Hematology Centers

Lung

Name: GENMAB What type of cancer is this for? Non-small-cell lung cancer Phase: II Who is this trial for? Men and women who have non-small-cell lung cancer that has spread to other parts of their body. What biomarkers are involved? Your tumor must have PD-L1 expression in greater than 1% of your tumor cells. What

Lymphoma

Name of the trial?  Abbvie M23-362 What type of cancer is this for?  Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma (previously Gr 1-3a) Phase of trial?  Phase 2 Who is this trial for?  Previously treated Follicular Lymphoma,  Now B-cell lymphoma.  Relapsed or refractory Follicular Lymphoma. What biomarkers are involved?  None What

Melanoma

NAME: IDE196-009 What kind of cancer is this for? Uveal melanoma Phase: II Who is this trial for? Men and women with primary uveal melanoma that requires either removal of the eye or radiation therapy. What biomarkers are involved? None What is National Clinical Trial #? NCT05907954 Brief summary of trial: This study is looking

Multiple Myeloma

Name: COBRA What kind of cancer is this for: Multiple Myeloma Phase: III Who is this trial for? Men and women who have just found out that they have multiple myeloma What biomarkers are involved? None What is National Clinical Trial#? NCT03729804 Brief summary of trial: This trial is looking at which treatment plan works

Myelofibrosis

Name of Trial:  Karyopharm XPORT-MF-034 What type of Cancer is this for?  Myelofibrosis (Blood cancer) Phase: 3 Who is this trial for? Patients with myelofibrosis or post-essential thrombocythemia (ET) or postpolycythemia-vera (PV) myelofibrosis. What biomarkers involved?  None What is the National Clinical Trial #? NCT04562389 Brief Summary: Purpose of this study is to evaluate the

Prostate

Name of this trial: MK-5684-004 What type of cancer is this for? PROSTATE cancer Phase of this trial? Phase III Who is this trial for? Men with prostate cancer that has spread while taking a next generation hormonal agent. What biomarkers are involved? None What is the National Clinical Trial#   NCT06136650  Brief summary of trial:

Registry Trial

NAME: EXACT- Registry trial What kind of cancer is this for? All cancer types Phase: N/A Who is this trial for? Men and women who either have a diagnosis of cancer, a clinical suspicion of cancer, a diagnosis of recurrent cancer or a clinical suspicion of recurrent cancer. What biomarkers are involved? Multiple What is